Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.
Carbonell-Estrany X, Simões EAF, Bont L, Manzoni P, Zar HJ, Greenough A, Ramilo O, Stein R, Law B, Mejias A, Sanchez Luna M, Checchia PA, Krilov L, Lanari M, Dagan R, Fauroux B, Resch B, Heikkinen T, Domachowske JB, Wildenbeest JG, Martinon-Torres F, Thwaites R, Cetinkaya M, Alharbi AS, Rodriguez-Martinez CE, Noyola DE, Kassim A, Kusuda S, Kang JM, Rodgers-Gray B, Platonova A, Jah F, Paes B.
Carbonell-Estrany X, et al. Among authors: manzoni p.
Expert Rev Anti Infect Ther. 2025 Jun;23(6):359-378. doi: 10.1080/14787210.2025.2481908. Epub 2025 Apr 1.
Expert Rev Anti Infect Ther. 2025.
PMID: 40111069
Free article.
Review.